Author:
Sun Qihang,Zheng Shubin,Tang Wei,Wang Xiaoyu,Wang Qi,Zhang Ruijie,Zhang Ni,Ping Wei
Publisher
Springer Science and Business Media LLC
Reference87 articles.
1. Herbst, R. S., Morgensztern, D. & Boshoff, C. The biology and management of non-small cell lung cancer. Nature 553, 446–454. https://doi.org/10.1038/nature25183 (2018).
2. Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 71, 209–249. https://doi.org/10.3322/caac.21660 (2021).
3. Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics 2022. CA Cancer J. Clin. 72, 7–33. https://doi.org/10.3322/caac.21708 (2022).
4. Zhang, J. et al. T cell-related prognostic risk model and tumor immune environment modulation in lung adenocarcinoma based on single-cell and bulk RNA sequencing. Comput. Biol. Med. 152, 106460. https://doi.org/10.1016/j.compbiomed.2022.106460 (2023).
5. Torre, L. A., Siegel, R. L. & Jemal, A. in Lung Cancer and Personalized Medicine: Current Knowledge and Therapies (eds Aamir Ahmad & Shirish Gadgeel) 1–19 (Springer International Publishing, 2016).